Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Laurion Capital Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Laurion Capital Management

Laurion Capital Management

Operating

Laurion Capital: A NYC-based investment firm managing diverse global assets since 2005.

Location
New York City, NY, US
Founded
2005
Firm
Compare
Portfolio
Employees
Website

Laurion Capital Management LP, based in New York City and founded in 2005, specializes in multi-disciplinary capital markets investing. The firm manages assets for foundations, endowments, family offices, pension funds, and other institutional and individual investors. Laurion Capital typically invests across various stages, including Seed, Series A, Series B, Series D, Series E, and Post-IPO Equity rounds. Their investment approach integrates both qualitative and quantitative research to identify opportunities across diverse asset classes.

Notable portfolio companies include Recursion Pharmaceuticals, SpringWorks Therapeutics, Synthego, and Schrödinger. Laurion Capital is led by a team of over 50 full-time employees who emphasize collaboration and inclusivity. Their investment philosophy centers on leveraging comprehensive data analysis to generate valuable insights. Laurion Capital also offers unique value-add services by focusing on robust processes and solutions that foster trust and teamwork within their investment strategy.

Laurion Capital Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments13
Current Portfolio Count9
Total Portfolio Exits2

Top Investment Stages

Series B3 (27.3%)
Post Ipo Equity2 (18.2%)
Series D2 (18.2%)
Series E2 (18.2%)
Series Unknown2 (18.2%)

Stage Mix

Series B 27%Post Ipo Equity 18%Series D 18%Series E 18%Series Unknown 18%

Concentration shown as share of disclosed investments by stage.

Recent Investments

MerQube logo

MerQube

Axoni logo

Axoni

Recursion Pharmaceuticals logo

Recursion Pharmaceuticals

Solid Biosciences logo

Solid Biosciences

TRex Bio logo

TRex Bio

Scipher Medicine logo

Scipher Medicine

Synthego logo

Synthego

AnHeart Therapeutics logo

AnHeart Therapeutics

Racket logo

Racket

Schrödinger logo

Schrödinger

SpringWorks Therapeutics logo

SpringWorks Therapeutics

Laurion Capital Management - Similar Investment Firms

Cape Capital logo

Cape Capital

capecapital.com

Empiricus logo

Empiricus

Luma Capital Partners logo

Luma Capital Partners

GlobalLink1 Capital logo

GlobalLink1 Capital

Iroquois Capital logo

Iroquois Capital

iroquoiscg.com

OpAmp Capital logo

OpAmp Capital

Firelake Capital Management logo

Firelake Capital Management

Sunrise Capital Partners logo

Sunrise Capital Partners

L Catterton Management logo

L Catterton Management

Composite Capital Management logo

Composite Capital Management

Fernbrook Capital Management logo

Fernbrook Capital Management

fernbrookmgmt.com

Surrey Capital Partners logo

Surrey Capital Partners

R3 Venture Partners logo

R3 Venture Partners

Triangle Peak Partners logo

Triangle Peak Partners

L37 Ventures logo

L37 Ventures

Laurion Capital Management - Classification

Also Known As
  • Laurion Capital Management LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions